Quarterly report pursuant to Section 13 or 15(d)

Unaudited Condensed Consolidated Statements of Operations

v3.20.1
Unaudited Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenue $ 0 $ 64
Operating expenses:    
Research and development 9,866 9,684
Selling, general and administrative 2,613 2,241
Total operating expenses 12,479 11,925
Loss from operations (12,479) (11,861)
Other (income) expense:    
Loss on extinguishment of debt 0 814
Amortization of debt issuance costs and discount 278 200
Interest income (147) (281)
Interest expense 210 367
Other income (350) 0
Warrant liabilities fair value adjustment (4,768) 6,522
Derivative liability fair value adjustment (700) 3,425
Total other (income) expense (5,477) 11,047
Net loss $ (7,002) $ (22,908)
Net loss per share - basic and diluted $ (0.07) $ (0.46)
Weighted average common shares outstanding – basic and diluted 97,445,775 49,317,575